Patent ID: 11925638
Assignee: ASTELLAS PHARMA INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 0:
1. A method of treating an AXL-related cancer, the method comprising:
administering an effective amount of a pharmaceutical composition to a subject in need thereof,
wherein the pharmaceutical composition comprises 6-ethyl-3-({3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)-5-(tetrahydro-2H-pyran-4-ylamino)pyrazine-2-carboxamide or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable excipient,
wherein the AXL-related cancer is cancer which has acquired resistance by the activation of AXL against therapy with an anticancer agent, and
wherein the cancer which has acquired resistance by the activation of AXL against therapy with an anticancer agent is acute myeloid leukemia, which has acquired resistance to chemotherapy.